Income Statement
SKYE BIOSCIENCE, INC.
SKYE
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Oct 31, 2013 2013 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Expenses
|
58.16 | 30.19 | 34.74 | 18.31 | 7.85 | 6.29 | 6.63 | 4.69 | 3.86 | 4.47 | 4.32 | 2.73 | 0.35 |
|
Research & Development
|
42.36 | 18.70 | 5.82 | 6.01 | 2.93 | 1.94 | 2.24 | 0.33 | 0.31 | 0.94 | 0.58 | 0.23 | - |
|
Selling, General & Administrative
|
15.80 | 17.73 | 7.85 | 6.09 | 4.92 | 4.34 | 4.39 | 4.36 | 3.55 | 3.53 | 3.74 | 2.50 | 0.03 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Operating Income
|
-58.16 | -30.19 | -34.74 | -18.31 | -7.85 | -6.29 | -6.63 | -4.69 | -3.86 | -4.47 | -4.32 | -2.73 | -0.35 |
|
Non-Operating Income
|
2.24 | 3.64 | -2.91 | -1.16 | -0.67 | -0.27 | 7.69 | 14.50 | -0.77 | -1.29 | 0.52 | - | 0.00 |
|
Interest Income
|
1.88 | 3.03 | 0.10 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | - | - | - | - | 0.00 |
|
Interest Expense
|
0.00 | 0.75 | 0.91 | 0.67 | 0.77 | 0.71 | 1.00 | 0.09 | 0.00 | - | - | - | 0.00 |
|
Other Non-Op Income / Expense
|
0.00 | 0.00 | - | - | - | - | - | - | - | - | - | - | - |
|
Income Before Tax
|
-55.92 | -26.56 | -37.64 | -19.47 | -8.52 | -6.56 | 1.05 | -19.19 | -3.09 | -3.18 | -4.84 | - | 0.00 |
|
Income Tax Expense
|
0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
Net Income
|
-55.92 | -26.57 | -37.64 | -19.48 | -8.52 | -6.56 | 1.05 | -19.19 | -3.09 | -3.18 | -4.84 | -2.73 | 0.00 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Oct 31, 2013 2013 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-57.44 | -29.89 | -34.74 | -18.31 | -7.85 | -6.29 | -6.63 | -4.69 | -3.86 | -4.47 | -4.32 | -2.73 | -0.35 |
|
Earnings Per Share (Basic)
|
-1.41 | -0.73 | -5.37 | -0.04 | -0.02 | -0.03 | 0.01 | - | -0.11 | - | - | - | - |
|
Diluted EPS
|
-1.41 | -0.73 | -5.37 | -0.04 | -0.02 | -0.03 | -0.05 | - | -0.11 | - | - | - | - |
|
Weighted Average Shares
|
39.66 | 36.49 | 7.01 | 555.27 | 406.60 | 230.75 | 135.15 | - | 27.91 | - | - | - | - |
|
Diluted Weighted Avg Shares
|
39.66 | 36.49 | 7.01 | 555.27 | 406.60 | 231.42 | 169.56 | - | 27.91 | - | - | - | - |
|
Comprehensive Income
|
- | - | - | - | - | - | - | - | - | - | - | - | - |